J-MAX - 64661-070-15 - (Dihydrocodeine Bitartrate, Guaifenesin)

Alphabetical Index


Drug Information of J-MAX

Product NDC: 64661-070
Proprietary Name: J-MAX
Non Proprietary Name: Dihydrocodeine Bitartrate, Guaifenesin
Active Ingredient(s): 7.5; 100    mg/5mL; mg/5mL & nbsp;   Dihydrocodeine Bitartrate, Guaifenesin
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of J-MAX

Product NDC: 64661-070
Labeler Name: JayMac Pharmaceuticals
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED DRUG OTHER
Start Marketing Date: 20080630

Package Information of J-MAX

Package NDC: 64661-070-15
Package Description: 15 mL in 1 BOTTLE (64661-070-15)

NDC Information of J-MAX

NDC Code 64661-070-15
Proprietary Name J-MAX
Package Description 15 mL in 1 BOTTLE (64661-070-15)
Product NDC 64661-070
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Dihydrocodeine Bitartrate, Guaifenesin
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 20080630
Marketing Category Name UNAPPROVED DRUG OTHER
Labeler Name JayMac Pharmaceuticals
Substance Name DIHYDROCODEINE BITARTRATE; GUAIFENESIN
Strength Number 7.5; 100
Strength Unit mg/5mL; mg/5mL
Pharmaceutical Classes Full Opioid Agonists [MoA],Opioid Agonist [EPC]

Complete Information of J-MAX


General Information